137 related articles for article (PubMed ID: 15016076)
41. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
Cheon MS; Dierssen M; Kim SH; Lubec G
Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
[TBL] [Abstract][Full Text] [Related]
42. Expression and significance of DSCAM in the cerebral cortex of APP transgenic mice.
Jia YL; Jing LJ; Li JY; Lu JJ; Han R; Wang SY; Peng T; Jia YJ
Neurosci Lett; 2011 Mar; 491(2):153-7. PubMed ID: 21241773
[TBL] [Abstract][Full Text] [Related]
43. Parkin overexpression ameliorates hippocampal long-term potentiation and β-amyloid load in an Alzheimer's disease mouse model.
Hong X; Liu J; Zhu G; Zhuang Y; Suo H; Wang P; Huang D; Xu J; Huang Y; Yu M; Bian M; Sheng Z; Fei J; Song H; Behnisch T; Huang F
Hum Mol Genet; 2014 Feb; 23(4):1056-72. PubMed ID: 24105468
[TBL] [Abstract][Full Text] [Related]
44. Aged SOD overexpressing mice exhibit enhanced spatial memory while lacking hippocampal neurogenesis.
Kamsler A; Avital A; Greenberger V; Segal M
Antioxid Redox Signal; 2007 Feb; 9(2):181-9. PubMed ID: 17115939
[TBL] [Abstract][Full Text] [Related]
45. Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury.
Corrigan F; Vink R; Blumbergs PC; Masters CL; Cappai R; van den Heuvel C
Brain Res; 2012 Apr; 1451():87-99. PubMed ID: 22424792
[TBL] [Abstract][Full Text] [Related]
46. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice.
Gahtan E; Auerbach JM; Groner Y; Segal M
Eur J Neurosci; 1998 Feb; 10(2):538-44. PubMed ID: 9749716
[TBL] [Abstract][Full Text] [Related]
47. Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD.
Borg J; Chereul E
J Neurosci Res; 2008 Nov; 86(15):3275-84. PubMed ID: 18646206
[TBL] [Abstract][Full Text] [Related]
48. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.
Iadecola C; Zhang F; Niwa K; Eckman C; Turner SK; Fischer E; Younkin S; Borchelt DR; Hsiao KK; Carlson GA
Nat Neurosci; 1999 Feb; 2(2):157-61. PubMed ID: 10195200
[TBL] [Abstract][Full Text] [Related]
49. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.
Schuessel K; Schäfer S; Bayer TA; Czech C; Pradier L; Müller-Spahn F; Müller WE; Eckert A
Neurobiol Dis; 2005 Feb; 18(1):89-99. PubMed ID: 15649699
[TBL] [Abstract][Full Text] [Related]
50. [Effect of free radicals on the permeability of the blood brain barrier--using in vitro blood brain barrier model of human-SOD transgenic mouse].
Kondo T; Imaizumi S; Kato I; Deli MA; Jóo F; Chan PH; Epstein CJ; Yoshimoto T
No To Shinkei; 1994 Dec; 46(12):1155-61. PubMed ID: 7893533
[TBL] [Abstract][Full Text] [Related]
51. Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1.
Shin JH; London J; Le Pecheur M; Höger H; Pollak D; Lubec G
Free Radic Biol Med; 2004 Sep; 37(5):643-53. PubMed ID: 15288122
[TBL] [Abstract][Full Text] [Related]
52. SOD-1 inhibits FAS expression in cortex of APP transgenic mice.
Chen Z; Duan RS; Lepécheur M; Paly E; London J; Zhu J
Apoptosis; 2005 May; 10(3):499-502. PubMed ID: 15909112
[TBL] [Abstract][Full Text] [Related]
53. Autoradiographic distribution of [3H]neurotensin receptors in the brains of superoxide dismutase transgenic mice.
Cadet JL; Kujirai K; Carlson E; Epstein CJ
Synapse; 1993 May; 14(1):24-33. PubMed ID: 8390106
[TBL] [Abstract][Full Text] [Related]
54. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
55. Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome.
Opazo P; Saud K; de Saint Pierre M; Cárdenas AM; Allen DD; Segura-Aguilar J; Caviedes R; Caviedes P
J Neurosci Res; 2006 Nov; 84(6):1303-10. PubMed ID: 16941497
[TBL] [Abstract][Full Text] [Related]
56. Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice.
Kamsler A; Segal M
J Neurosci; 2003 Nov; 23(32):10359-67. PubMed ID: 14614095
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy.
Rando TA; Crowley RS; Carlson EJ; Epstein CJ; Mohapatra PK
Ann Neurol; 1998 Sep; 44(3):381-6. PubMed ID: 9749606
[TBL] [Abstract][Full Text] [Related]
58. Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene.
Barkats M; Bertholet JY; Venault P; Ceballos-Picot I; Nicole A; Phillips J; Moutier R; Roubertoux P; Sinet PM; Cohen-Salmon C
Neurosci Lett; 1993 Sep; 160(1):24-8. PubMed ID: 8247326
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of GABA neurotransmission suppresses hippocampal excitability and prevents long-term potentiation in transgenic superoxide dismutase-overexpressing mice.
Levkovitz Y; Avignone E; Groner Y; Segal M
J Neurosci; 1999 Dec; 19(24):10977-84. PubMed ID: 10594078
[TBL] [Abstract][Full Text] [Related]
60. APP/SOD1 overexpressing mice present reduced neuropathic pain sensitivity.
Kotulska K; Larysz-Brysz M; LePecheur M; Marcol W; Olakowska E; Lewin-Kowalik J; London J
Brain Res Bull; 2011 Jul; 85(6):321-8. PubMed ID: 21605634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
